Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | McElrath: Innate to Adaptive Immunity |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-07-02 |
| Study Made Public: | 2016-03-30 |
Title
VRC 422: A study assessing effects of the adjuvants: alum, alum/TLR7 agonist, MF59 and polyIC on HIV TV1 gp140 immunity in nonhuman primates
Description
CAVD 417 (VRC 422) is a non-human primate study of protein and adjuvant regimens. This was a follow up study to confirm the results of CAVD 266.
Sign in to see full information about this study and to download study data.
Products
Alum Saline (non-specific) MF59 Poly ICLC TLR7 Env gp140 TV1Integrated data
NAb
Non-integrated data
No non-integrated data is available for this study.